Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
reported fourth-quarter 2025 financial results that fell short of Wall Street's expectations on both revenue and profit. Revenue for the quarter came in at $183.1 million, a 1.8% decline year-on-year that missed analyst forecasts. The company's adjusted earnings per share of $0.73 also fell short of consensus estimates and was down from $0.92 in the same quarter last year. Adding to the concerns, Amphastar's operating margin contracted to 19.4% from 24.2% in the prior-year period, indicating a decline in profitability as its expenses increased relative to revenue. Overall, the results showed slowing growth and weakening profitability, which disappointed investors. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Amphastar Pharmaceuticals? Access our full analysis report here, it's free What Is The Market Telling Us Amphastar Pharmaceuticals's shares are quite volatile and have had 16 move
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals (AMPH) had its price target lowered by Wells Fargo & Company from $34.00 to $30.00. They now have an "overweight" rating on the stock.MarketBeat
- Amphastar Pharmaceuticals (AMPH) had its price target lowered by Needham & Company LLC from $34.00 to $30.00. They now have a "buy" rating on the stock.MarketBeat
- Amphastar Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7% [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 2/26/26 - Miss
AMPH
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 1/12/26 - Form 8-K
- AMPH's page on the SEC website